The conference will feature highly organized sessions involving delegates drawn from different sectors of the pharmaceutical industry as an audience to select speakers drawn from various regulatory bodies and organizations.
The conference features presentation sessions that are later on backed by panel discussions that shed greater light on topics discussed, in a largely interactive session within the day.
Some of the topics, which are available on the conference programme for delegates and participants will include the following;
- Pre-market regulatory requirements for medical products (Kenyan, Ugandan, Tanzanian experience and industry perspective)
- Pharmaco-vigilance of Medical products
- Post-market surveillance of medical products
- Good distribution practices and parallel importation
These are some of the topics and agenda of interest that will be put to plenary during the two day event.
Speakers will have presentation sessions that may last about an hour and a half, followed by plenary discussions. The sequence of events is represented in the programme of events available to delegates and participants.
In summary, the conference and exhibition will include the following;
In this part of the format of the event, leading pharma/biotech experts and company executives will give their presentations and view of the current issues and future challenges of the industry. The addresses will feature prominent topics of interest in regard to regulation and compliance for the benefit of the delegates.
Panel comprising some of the well-known thinkers and innovators in biotech/pharma technology, regulatory compliance and quality will discuss and debate the hottest issues affecting the industry. Attendees will be able to interact with the panel members during these debates and get unparraled insight into the state of the industry
Attendees will get to interact with and meet the leading decision makers in the industry in order to exchange ideas, discuss business opportunities and share strategies in focused small groups for synergy.
This will be a unique opportunity for biotech and pharma companies both big and small, technological companies and other players in the pharmaceutical supply chain to market their offerings and identify new business opportunities.